Vestnik dermatologii i venerologiiVestnik dermatologii i venerologiiВестник дерматологии и венерологии0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov57210.25208/vdv572ArticlesСтатьиResearch ArticleEfficacy of skin care products for acne patientsЭффективность средств ухода за кожей у больных акнеAraviyskayaYe RАравийскаяЕ Р

д.м.н., профессор кафедры дерматовенерологии с клиникой

arelenar@mail.ruSokolovskyYe VСоколовскийЕ В

д.м.н., профессор кафедры дерматовенерологии с клиникой

Pavlov State Medical UniversityГБОУ ВПО «Санкт-Петербургский государственный медицинский университет им. академика И.П. Павлова» Минздрава России15042013892NO2 (2013)№2 (2013)677111032020Copyright ©; 2013, Araviyskaya Y.R., Sokolovsky Y.V.Copyright ©; 2013, Аравийская Е.Р., Соколовский Е.В.2013Araviyskaya Y.R., Sokolovsky Y.V.Аравийская Е.Р., Соколовский Е.В.https://creativecommons.org/licenses/by/4.0https://vestnikdv.ru/jour/article/view/572

The article provides information about barrier skin properties in acne patients and analyzes the effects of topical and systemic drugs on the condition of the corneous layer as well as composition of highly specialized lipids and skin fat. It discusses the principles of patient management with the use of basic daily care products.

Представлены сведения о состоянии барьерных свойств кожи у пациентов с акне, анализируется действие топических и системных препаратов на состояние рогового слоя, а также состав высокоспециализированных липидов и кожного сала. Обсуждаются принципы ведения пациентов с использованием средств для ежедневного базового ухода.

acneskin barrier propertiesbasic careCetaphil Dermacontrolакнеэпидермальный барьерСетафилNast A., Dreno B., Bettoli V., Degitz K. et al. European evidence-based (S3) guidelines for the treatment of acne. JEADV 2012; 26: 1: 1—29.Thiboutot D., Gollnick H.P., Bettoli V., Dreno B. et al. New insights into the management of acne: An update from the Global Alliacne to improve outcomes in acne group. JAAD 2009; 60: 5: 1—50.Kubanova A.A. Clinical Guidelines. Moscow: ZAO FID Delovoi express 2010Руководство по дерматокосметологии. Под ред. Е.Р. Аравийской и Е.В. Соколовского. CПб: Фолиант 2008; 632.Korolev Yu.F. Change of composition of skin fat at a seborrhea. Vestnik dermatologii i venerologii.1958; (4): 9—14.Yamamoto A., Takenouchi K., Ito M. Impaired water barrier function in acne vulgaris. Arch Dermatol Res 1995; 287: 214—218.Strauss J.S., Thiboutot D.M. Diseases of the sebaceous glands. In: Freeberg I., Elsen A., Wolff K. et al., eds. Fitzpatrick’s Dermatology in General Medicine. 5-th ed., New York, NY: McGraw-Hill; 1999: 769.Downing D.T., Stewart M.E., Wertz P.W., Strauss J.S. Essential fatty acids and acne. J Am Acad Dermatol 1986 F; 14 (2 Pt 1): 221—5.Jeremy A.H., Holland D.B., Roberts S.G., Thomson K.F., Cunliffe W.J. Inflammatory events are in volved in acne lesion initiation. J Invest Dermatol 2003 Jul; 121 (1): 20—7.Freinkel R.K. Acne vulgaris: follicles, fats and flora, Cutis 1971; 7: 409.Stewart M.E., Benoit A.M., Downing D.T. et al. Suppression of sebum secretion with 13-cis retinoic acid: effect on individual skin surface lipids and implications for their anatomic origin. J Invest Dermatol 1984; 82: 74—78.King R., Jones D.H., Darley D.S. et al. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. BJD 1982; 107: 583—590.Bikowsky J.B. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J Drug Dermatol 2005; 4: 41—47.Cunliffe W.J. Acne. London: Martin Dunitz 1988: 392.Gollnick H.P., Draelos Z., Glenn M.J., Rosoph L.A. et al. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol 2009; 161 (5): 1180—1189.Dreno B., Thiboutot D., Gollnick H. et al. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol 2010; 49: 448—456.Thielitz A., Helmdach M., Röpke E.M., Gollnick H. Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents. Br J Dermatol 2001; 145: 19—27.Samcov A.V. Akne i akneiformnye dermatozy. Monografija. M.: JuTKOM; 2009Cunliffe W.J., Cotterill J.A., Williamson B. The effect of clindamycin in acne — a clinical and laboratory investigation.Br JD 1972; 87: 37—41.Thiboutot D., Shalita A., Yamauchi P.S., Dawson C. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study. Skinmed, 2005; 4: 138—146.Dreno B., Foulc P., Reynaud A., et al. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Eur J Dermatol 2005 May-Jun; 15 (3): 152—5.Draelos Z.D. Sensitive skin: perceptions, evaluation, and treatment. Contact Dermatitis 1997; 8:67.Baran R., Maibach H.I. Textbook of cosmetic Dermatology. Martin Dunitz Ltd 1998: 99—167.Jackson E.M. The effects of cleansing in an acne treatment regiment. Cosmet Dermatol. 2000; 12 (suppl.): 9.Swinyer L.J., Swinyer T.A., Britt M.R. Topical agents all one in acne. JАMА 1980, 243: 16—40.Lynde C. Moisturizers for the treatment of inflammatory skin conditions. J Drugs Dermatol 2008 N; 7 (11): 1038—43.Baumann L., Saghari S., Weisberg E. Cosmetic Dermatology. Principles and practice. 2-nd ed. McGraw-Hill Companies, Inc. 2009: 121—128.Draelos Z.D., Dover J.S., Alam M. Cosmeceuticals, 2-nd ed., Elseiver Inc 2009; 236.Goodman G. Cleansing and Moisturizing in Acne Patients. Am J Clin Dermatol 2009; 10: 1: 1—6.